Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
HQL:US
New York
17.44
USD
0.32
1.80%
As of 20:04:05 ET on 02/05/2016.
Open
17.75
Day Range
17.23 - 17.77
Previous Close
17.76
52Wk Range
17.06 - 30.32
1 Yr Return
-26.87%
YTD Return
-26.23%
Open
17.75
Day Range
17.23 - 17.77
Volume
86,817
Previous Close
17.76
52Wk Range
17.06 - 30.32
1 Yr Return
-28.01%
YTD Return
-26.23%
NAV (on 02/05/2016)
18.35
Total Assets (m USD) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Premium/Discount
-4.96%
Average 52-Week Premium
-0.38%
Fund Managers
DANIEL R OMSTEAD "DAN"
Last Dividend (on 12/28/2015)
0.71
Dividend Indicated Gross Yield
10.78%
Expense Ratio
1.17%
3 Mo Return
-29.91%
3 Yr Return
13.84%
5 Yr Return
19.67%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 443.12 k 43.51 m 9.40
Celgene Corp 371.52 k 40.19 m 8.68
Incyte Corp 259.92 k 28.68 m 6.20
Biogen Inc 79.51 k 23.20 m 5.01
Regeneron Pharmaceuticals Inc 44.62 k 20.76 m 4.48
Alexion Pharmaceuticals Inc 127.80 k 19.99 m 4.32
Vertex Pharmaceuticals Inc 191.38 k 19.93 m 4.31
Illumina Inc 92.73 k 16.30 m 3.52
Teva Pharmaceutical Industries 287.32 k 16.22 m 3.50
Mylan NV 390.32 k 15.71 m 3.40
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500